[1] Cattano D, Van Zundert TCRV, Wojtczak J. Laryngeal mask airway and the enigma of anatomical sizing. J Clin Monit Comput. 2019 Apr 24.
[2] Hohlrieder M, Brimacombe J, von Goedecke A, et al. Postoperative nausea, vomiting, airway morbidity, and analgesic requirements are lower for the ProSeal laryngeal mask airway than the tracheal tube in females undergoing breast and gynaecological surgery. Br J Anaesth. 2007 Oct;99(4):576-80.
[3] Erhan E, Ugur G, Anadolu O, et al. General anaesthesia or spinal anaesthesia for outpatient urological surgery. Eur J Anaesthesiol. 2003 Aug;20(8):647-52.
[4] Baker AR, Baker AB. Anaesthesia for endoscopic sinus surgery. Acta Anaesthesiol Scand. 2010 Aug;54(7):795-803.
[5] Hu LQ, Leavitt OS, Malwitz C, et al. Comparison of laryngeal mask airway insertion methods, including the external larynx lift with pre-inflated cuff, on postoperative pharyngolaryngeal complications: A randomized clinical trial. Eur J Anaesthesiol. 2017 Jul;34(7):448-455.
[6] Scanlon P, Carey M, Power M, et al. Patient response to laryngeal mask insertion after induction of anaesthesia with propofol or thiopentone. Can J Anaesth. 1993 Sep;40(9):816-8.
[7] Chandra S, Pryambodho P, Melati AC, et al. Comparison Between Lidocaine Inhalation and Intravenous Dexamethasone in Reducing Postoperative Sore Throat Frequency After Laryngeal Mask Insertion. Anesth Pain Med. 2018; 25;8(5): e82131.
[8] Eichelsbacher C, Ilper H, Noppens R, et al. Rapid sequence induction and intubation in patients with risk of aspiration: Recommendations for action for practical management of anesthesia]. Anaesthesist. 2018;67(8):568-583.
[9] Michel J, Hofbeck M, Gerbig I, et al. Nurse-driven analgesia and sedation in pediatric patients with univentricular hearts requiring extracorporeal life support after first-stage palliation surgery: A pilot study. Paediatr Anaesth. 2017; 27(12):1261-1270.
[10] Nasseri K. Effect of Low-dose Atracurium on Laryngeal Mask Airway Insertion Conditions: A Randomized Double-blind Clinical Trial. Adv Biomed Res, 2017, 6(1): 119.
[11] Ortiz JR, Percaz JA, Carrascosa F. [Cisatracurium]. Rev Esp Anestesiol Reanim. 1998; 45(6):242-7.
[12] Fuchs-Buder T. New muscle relaxants. Update on mivacurium, rocuronium and cis-atracurium. Anaesthesist. 1997; 46(4):350-9.
[13] Diefenbach C, Buzello W. New muscle relaxants. Anasthesiol Intensivmed Notfallmed Schmerzther. 1996;31(1):2-8.
[14] Savarese JJ, Wastila WB. The future of the benzylisoquinolinium relaxants. Acta Anaesthesiol Scand Suppl 1995; 106:91-93.
[15] Konrad FM, Unertl KE, Schroeder TH. Mastocytosis. A challenge in anaesthesiology. Anaesthesist. 2009; 58(12):1239-43.
[16] Kim KS, Chun YS, Chon SU, et al. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination. Anaesthesia. 1998;53(9):872-8.
[17] Bergeron L, Bevan DR, Berrill A, et al. Concentration–effect relationship of cisatracurium at three different dose levels in the anesthetized patient. Anesthesiology. 2001; 95:314–23.
[18] Naguib M, Samarkandi AH, Ammar A, et al. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination. Anesthesiology. 1998;89(5):1116-24.
[19] Kim JH, Lee YC, Lee SI, et al. Effective doses of cisatracurium in the adult and the elderly. Korean J Anesthesiol. 2016;69(5):453-459.
[20] Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991;15(1):47-50.
[21] Sivalingham P, Kandasamy R, Madhaven G, et al. Conditions for laryngeal mask insertion: A comparison of propofol versus sevoflurane with or without alfentanil. Anaesthesia 1999; 54:271–6.
[22] Naguib M, Samarkandi AH, Ammar A, et al. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination. Anesthesiology. 1998; 89(5):1116-24.
[23] Wulf H, Kahl M, Ledowski T. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v.anaesthesia. Br J Anaesth. 1998; 80(3):308-12.
[24] Park WY, Choi JC, Yun HJ, et al. Optimal dose of combined rocuronium and cisatracurium during minor surgery: A randomized trial. Medicine (Baltimore). 2018;97(10): e9779.
[25] Belmont MR, Lien CA, Quessy S, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995; 82: 1139-45.
[26] Lepage JY, Malinovsky JM, Malinge M, et al. Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia. Anesth Analg 1996; 83: 823-9.
[27] George L R, Sahajanandan R, Ninan S. Low-dose Succinylcholine to Facilitate Laryngeal Mask Airway Insertion: A Comparison of Two Doses. Anesth Essays Res, 2017, 11(4): 1051-1056.
[28] Smith SE, Hamblin SE, Dennis BM. Effect of Neuromuscular Blocking Agents on Sedation Requirements in Trauma Patients with an Open Abdomen. Pharmacotherapy. 2019; 39(3):271-279.
[29] Naguib M, Lien CA, Meistelman C. Pharmacology of muscle relaxants and their antagonists. In: Miller’s Anesthesia. 8th ed. Edited by Miller RD: Philadelphia, Churchill Livingstone/Elsevier. 2015, pp 958-94.
[30] Kisor DF, Schmith VD. Clinical pharmacokinetics of cisatracurium besilate. Clin Pharmacokinet 1999; 36: 27-40.
[31] Sorooshian SS, Stafford MA, Eastwood NB, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Anesthesiology 1996; 84: 1083-91.
[32] Amin AM, Mohammad MY, Ibrahim MF. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia. Middle East J Anaesthesiol. 2009; 20(1):39-51.
[33] Kim YB, Sung TY, Yang HS. Factors that affect the onset of action ofnon-depolarizing neuromuscular blocking agents. Korean J Anesthesiol. 2017; 70:500–10.
[34] Ornstein E, Lien CA, Matteo RS, et al. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology 1996; 84: 520-5.
[35] Leykin Y, Pellis T, Lucca M, et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg 2004; 99:1086–9.
[36] Arain SR, Kern S, Ficke DJ, et al. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta Anaesthesiol Scand 2005; 49: 312-5.
[37] Naguib M. Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination. Anesthesiology 1994; 81:388–95.
[38] Tulgar S, Boga I, Cakiroglu B, et al. Short-lasting pediatric laparoscopic surgery: Are muscle relaxants necessary? Endotracheal intubation vs. laryngeal mask airway. Journal of Pediatric Surgery, 2017, 52(11): 1705-1710.
[39] Hemmerling T M, Michaud G, Deschamps S, et al. 'Patients who sing need to be relaxed'--neuromuscular blockade as a solution for air-leaking during intermittent positive pressure ventilation using LMA. Can J Anaesth, 2005, 52(5): 549.